Lipid Profile, PCSK9, ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High‐Grade Prostate Cancer and Men At‐Risk of Prostate Cancer

Lipid Profile, PCSK9, ANGPTL3 and Lipoprotein (a) Levels in Men Diagnosed With Localized High‐Grade Prostate Cancer and Men At‐Risk of Prostate Cancer

ABSTRACT Background Some cancers have been found to require abundant supplies of lipids for their development. One example is prostate cancer (PCa). To date, lipid‐modifying factors, such as proprotein convertase subtilisin/kexin type 9 (PCSK9), angiopoietin‐like 3 protein (ANGPTL3), and lipoprotein...

Full description

Saved in:
Bibliographic Details
Main Authors: Ann‐Charlotte Bergeron, Emilie Wong‐Chong, France‐Hélène Joncas, Chloé Castonguay, Frédéric Calon, Nabil G. Seidah, Jonatan Blais, Karine Robitaille, Alain Bergeron, Vincent Fradet, Anne Gangloff
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Cancer Medicine
Subjects:
ANGPTL3
lipid‐lowering drugs targets
lipoprotein (a)
PCSK9
prostate cancer
Online Access:https://doi.org/10.1002/cam4.70587
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.1002/cam4.70587

Similar Items